| scholarly article | Q13442814 |
| P50 | author | Mildred Cho | Q59750202 |
| P2093 | author name string | Megan Allyse | |
| Mary E Norton | |||
| Lauren C Sayres | |||
| P2860 | cites work | ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities | Q22242787 |
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
| The obstetrician's view: ethical and societal implications of non-invasive prenatal diagnosis | Q36541764 | ||
| MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. | Q36986986 | ||
| Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma | Q37000915 | ||
| Non-invasive prenatal diagnosis: public and patient perceptions | Q37082184 | ||
| ACOG Committee Opinion No. 410: Ethical issues in genetic testing | Q37178706 | ||
| Future directions in genetic counseling: practical and ethical considerations. | Q40680538 | ||
| Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood | Q44645735 | ||
| Nondirectiveness in prenatal genetics: patients read between the lines | Q47715315 | ||
| Practical and ethical considerations of noninvasive prenatal diagnosis. | Q51933954 | ||
| Ethical decision-making in prenatal diagnosis and termination of pregnancy: a qualitative survey among physicians and midwives. | Q53417897 | ||
| Inserting Government between Patient and Physician | Q53473941 | ||
| Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Sex selection and preimplantation genetic diagnosis. The Ethics Committee of the American Society of Reproductive Medicine | Q58672867 | ||
| Prenatal genetic testing: content of discussions between obstetric providers and pregnant women | Q74509581 | ||
| ACOG Committee Opinion No. 360: Sex selection | Q79701094 | ||
| A survey of the practices and opinions of the domestic members of the American Society for Reproductive Medicine | Q80579173 | ||
| Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting | Q83395075 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1070-1076 | |
| P577 | publication date | 2011-07-27 | |
| P1433 | published in | Prenatal Diagnosis | Q15760059 |
| P1476 | title | Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation | |
| P478 | volume | 31 |
| Q35542250 | "Don't Want No Risk and Don't Want No Problems": Public Understandings of the Risks and Benefits of Non-Invasive Prenatal Testing in the United States |
| Q37624999 | "I think we've got too many tests!": Prenatal providers' reflections on ethical and clinical challenges in the practice integration of cell-free DNA screening. |
| Q38780309 | A Framework for Unrestricted Prenatal Whole-Genome Sequencing: Respecting and Enhancing the Autonomy of Prospective Parents |
| Q38449983 | Attitudes and Knowledge of Maternal-Fetal Medicine Fellows Regarding Noninvasive Prenatal Testing. |
| Q47586884 | Attitudes towards non-invasive prenatal diagnosis among obstetricians in Pakistan, a developing, Islamic country |
| Q35447245 | Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age. |
| Q58302535 | Balancing Risks: The Core of Women's Decisions About Noninvasive Prenatal Testing |
| Q33754305 | Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing |
| Q36321452 | Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context |
| Q39200097 | Client views and attitudes to non-invasive prenatal diagnosis for sickle cell disease, thalassaemia and cystic fibrosis |
| Q34315923 | Demographic and experiential correlates of public attitudes towards cell-free fetal DNA screening |
| Q30847203 | Development and evaluation of training resources to prepare health professionals for counselling pregnant women about non-invasive prenatal testing for Down syndrome: a mixed methods study |
| Q58662378 | Emerging ethical issues in reproductive medicine: are bioethics educators ready? |
| Q58106704 | Ethical Concerns in the Implementation of DNA Sequencing-Based Noninvasive Prenatal Testing for Fetal Aneuploidy Among Obstetric Professionals in Hong Kong |
| Q34480344 | Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol |
| Q38119478 | Factors affecting the clinical use of non-invasive prenatal testing: a mixed methods systematic review |
| Q57839584 | Fetal sex determination using cell-free fetal DNA: service users' experiences of and preferences for service delivery |
| Q89303078 | Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians |
| Q43570601 | Genetic counselors' experience with cell-free fetal DNA testing as a prenatal screening option for aneuploidy |
| Q37082232 | Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy |
| Q35667260 | It's More Than a Blood Test: Patients' Perspectives on Noninvasive Prenatal Testing |
| Q35060714 | Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong |
| Q39213958 | NIPT: current utilization and implications for the future of prenatal genetic counseling. |
| Q36847554 | Non-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women's Healthcare Practitioners |
| Q37044362 | Non-invasive prenatal testing for single gene disorders: exploring the ethics |
| Q43469221 | Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice |
| Q39113200 | Non-invasive prenatal testing: UK genetic counselors' experiences and perspectives |
| Q38549770 | Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA |
| Q64232954 | Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment |
| Q50191785 | Obstetrical provider knowledge and attitudes towards cell-free DNA screening: results of a cross-sectional national survey |
| Q38418823 | Overview of the impact of noninvasive prenatal testing on diagnostic procedures |
| Q93265239 | Physicians' perception toward non-invasive prenatal testing through the eye of the Rogers' diffusion of innovation theory in China |
| Q34853996 | Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of women |
| Q50122383 | Trends in Fetal Medicine: A 10-Year Bibliometric Analysis of Prenatal Diagnosis |
| Q40701080 | Use of the Combined First-Trimester Screen in High- and Low-Risk Patient Populations After Introduction of Noninvasive Prenatal Testing |
| Q56772393 | Views and preferences for the implementation of non-invasive prenatal diagnosis for single gene disorders from health professionals in the United Kingdom |
| Q58301130 | What Is “NIPT”? Divergent Characterizations of Noninvasive Prenatal Testing Strategies |
| Q46106095 | Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting |
Search more.